Recently, NK cell adaptation and HCMV infection have been shown to enhance NK cell expression of PD-1, TIM-3 and CEACAM-1 (CD66a), inhibitory molecules whose signaling slows NK cell proliferation and diminish NK cell pro-inflammatory activities [82,83]. This evidence concerns the gene CEACAM1 and cytomegalovirus infection.